[HTML][HTML] Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

P Calabresi, A Mechelli, G Natale… - Cell death & …, 2023 - nature.com
Although the discovery of the critical role of α-synuclein (α-syn) in the pathogenesis of
Parkinson's disease (PD) is now twenty-five years old, it still represents a milestone in PD …

A new era for understanding amyloid structures and disease

MG Iadanza, MP Jackson, EW Hewitt… - … reviews Molecular cell …, 2018 - nature.com
The aggregation of proteins into amyloid fibrils and their deposition into plaques and
intracellular inclusions is the hallmark of amyloid disease. The accumulation and deposition …

Role of mitochondrial ROS in the brain: from physiology to neurodegeneration

PR Angelova, AY Abramov - FEBS letters, 2018 - Wiley Online Library
Mitochondria are key cell organelles in that they are responsible for energy production and
control many processes from signalling to cell death. The function of the mitochondrial …

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease

EM Rocha, B De Miranda, LH Sanders - Neurobiology of disease, 2018 - Elsevier
Parkinson's disease (PD) is a complex, chronic and progressive neurodegenerative
disease. While the etiology of PD is likely multifactorial, the protein α-synuclein is a central …

The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer's disease and Parkinson's disease

G Monzio Compagnoni, A Di Fonzo, S Corti… - Molecular …, 2020 - Springer
Although the pathogenesis of neurodegenerative diseases is still widely unclear, various
mechanisms have been proposed and several pieces of evidence are supportive for an …

[HTML][HTML] α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease

MHR Ludtmann, PR Angelova, MH Horrocks… - Nature …, 2018 - nature.com
Protein aggregation causes α-synuclein to switch from its physiological role to a pathological
toxic gain of function. Under physiological conditions, monomeric α-synuclein improves ATP …

[HTML][HTML] Mitochondrial dysfunction in Parkinson's disease–a key disease hallmark with therapeutic potential

MT Henrich, WH Oertel, DJ Surmeier… - Molecular …, 2023 - Springer
Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic
Parkinson's disease (PD). However, strategies aimed at ameliorating mitochondrial …

[HTML][HTML] New insights into the complex role of mitochondria in Parkinson's disease

A Grünewald, KR Kumar, CM Sue - Progress in neurobiology, 2019 - Elsevier
New discoveries providing insights into mitochondrial bioenergetics, their dynamic
interactions as well as their role in cellular homeostasis have dramatically advanced our …

[HTML][HTML] Interaction of mitochondrial calcium and ROS in neurodegeneration

AY Baev, AY Vinokurov, IN Novikova, VV Dremin… - Cells, 2022 - mdpi.com
Neurodegenerative disorders are currently incurable devastating diseases which are
characterized by the slow and progressive loss of neurons in specific brain regions …

[HTML][HTML] α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production

S Paillusson, P Gomez-Suaga, R Stoica, D Little… - Acta …, 2017 - Springer
Abstract α-Synuclein is strongly linked to Parkinson's disease but the molecular targets for its
toxicity are not fully clear. However, many neuronal functions damaged in Parkinson's …